透到瘤免疫微环境中的重编程,并将其优化为免疫疗法
Zhaokai Zhou1,2, Jiaxin Xu1,3, Shutong Liu1
1Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Biomarker research
|September 3, 2024
概括
向透瘤的调节性T细胞 (Tregs) 提供了一个新的癌症免疫治疗策略. 在瘤微环境中重新编程这些细胞可以增强抗瘤免疫力,没有系统性自身免疫副作用.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 免疫疗法对瘤有希望,但面临来自免疫抑制性瘤免疫微环境 (TIME) 的挑战.
- 透的调节性T细胞 (Tregs) 显著促进了TIME免疫抑制,阻碍了抗瘤免疫反应.
- 系统性Treg消耗/抑制可以增强抗瘤免疫力,但会导致有害的自身免疫效应.
研究的目的:
- 审查针对瘤透 (TI) -Tregs. 的新兴策略.
- 讨论TI-Tregs的重编程以增强抗瘤免疫力.
- 探索利用Treg重编程知识用于新型癌症免疫疗法.
主要方法:
- 关于TI-Treg准策略的当前研究的文献综述.
- 分析瘤微环境中的Treg重编程机制.
- 综合发现,提出新的免疫疗法方法.
主要成果:
- 新兴的战略重点是重新编程TI-Tregs,而不是系统性耗尽.
- 重编程TI-Tregs可以增强抗瘤免疫力,同时减轻自身免疫风险.
- 了解Treg调节机制是开发有效疗法的关键.
结论:
- 准TI-Tregs代表了癌症免疫治疗的有希望的途径.
- 重编程TI-Tregs为克服瘤诱导的免疫抑制提供了一个潜在的策略.
- 对Treg重编程机制的进一步研究可以改善癌症治疗.
相关概念视频
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
T Cell Types and Functions
963
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
963


